Tested Applications
| Positive WB detected in | mouse liver tissue, human liver tissue, human brain tissue, A549 cells, HeLa cells, rat liver tissue, A431 cells, HepG2 cells |
| Positive IHC detected in | human liver cancer tissue, human kidney tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF/ICC detected in | Hela cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:3000 |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:10-1:100 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
15759-1-AP targets LHPP in WB, IHC, IF/ICC, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human, mouse, rat |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag8375 Product name: Recombinant human LHPP protein Source: e coli.-derived, PET28a Tag: 6*His Domain: 1-210 aa of BC007324 Sequence: MAPWGKRLAGVRGVLLDISGVLYDSGAGGGTAIAGSVEAVARLKRSRLKVRFCTNESQKSRAELVGQLQRLGFDISEQEVTAPAPAACQILKERGLRPYLLIHDGVRSEFDQIDTSNPNCVVIADAGESFSYQNMNNAFQVLMELEKPVLISLGKGRYYKETSGLMLDVGPYMKALEYACGIKAEVVGKPSPEFFKSALQAIGVEAHQAQ Predict reactive species |
| Full Name | phospholysine phosphohistidine inorganic pyrophosphate phosphatase |
| Calculated Molecular Weight | 23 kDa, 29 kDa |
| Observed Molecular Weight | 23-32 kDa |
| GenBank Accession Number | BC007324 |
| Gene Symbol | LHPP |
| Gene ID (NCBI) | 64077 |
| RRID | AB_2296904 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9H008 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for LHPP antibody 15759-1-AP | Download protocol |
| IHC protocol for LHPP antibody 15759-1-AP | Download protocol |
| WB protocol for LHPP antibody 15759-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The LHPP antibody (Cat# 15759-1-AP) has 18 total citations published in journals including Molecular Cancer, Cell Death & Disease, Cancer Letters, Cell Reports, FASEB Journal, Aging, International Immunopharmacology, and BMC Medical Genomics. Research fields cover oncology (prostate, gastric, hepatocellular, nasopharyngeal, colorectal, bladder, and lung cancers), ferroptosis, liver fibrosis, neurogenesis, and colitis, involving AKT, PI3K/AKT/mTOR, EGFR, and TGF-β/Smad3 signaling pathways.
| Species | Application | Title |
|---|---|---|
Mol Cancer YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer. | ||
Cell Death Dis Phosphatase LHPP confers prostate cancer ferroptosis activation by modulating the AKT-SKP2-ACSL4 pathway | ||
Cell Death Dis Targeting LHPP in neoadjuvant chemotherapy resistance of gastric cancer: insights from single-cell and multi-omics data on tumor immune microenvironment and stemness characteristics | ||
Cancer Lett HDAC4 mediated LHPP deacetylation enhances its destabilization and promotes the proliferation and metastasis of nasopharyngeal carcinoma | ||
Cell Rep LHPP-mediated inorganic pyrophosphate hydrolysis-driven lysosomal acidification in astrocytes regulates adult neurogenesis
| ||
Aging (Albany NY) The long intergenic noncoding RNA GAS5 reduces cisplatin-resistance in non-small cell lung cancer through the miR-217/LHPP axis.
|























